A highly sensitive fluorescence biosensor for the detection of cytochrome c based on polydopamine nanotubes and exonuclease I amplification

2021 ◽  
Author(s):  
yanmei shen ◽  
Xueping Shen ◽  
Jia Ge ◽  
Lingbo Qu ◽  
Zhaohui Li

Cytochrome c (Cyt c), as an important biomarker, plays an important role in cell apoptosis and mitochondrial electron transport chain. Here, we have developed a novel biosensor for the Cyt...

RSC Advances ◽  
2015 ◽  
Vol 5 (36) ◽  
pp. 28258-28269 ◽  
Author(s):  
Zhi-Peng Wang ◽  
Xiao-Zhe Ding ◽  
Jun Wang ◽  
Yi-Ming Li

Besides functioning as an electron transporter in the mitochondrial electron transport chain, cytochrome c (cyt c) is also one of the determinants in the execution of cell death.


Author(s):  
Hasini A. Kalpage ◽  
Junmei Wan ◽  
Paul T. Morse ◽  
Matthew P. Zurek ◽  
Alice A. Turner ◽  
...  

2014 ◽  
Vol 459 (1) ◽  
pp. 127-135 ◽  
Author(s):  
Vladimir Klichko ◽  
Barbara H. Sohal ◽  
Svetlana N. Radyuk ◽  
William C. Orr ◽  
Rajindar S. Sohal

The suppression of cytochrome c oxidase function exerts deleterious rather than benign effects on fitness and survival. The structure/function of cytochrome c oxidase, a mitochondrial electron-transport chain oxidoreductase, can be re-engineered in vivo.


Science ◽  
2013 ◽  
Vol 340 (6140) ◽  
pp. 1567-1570 ◽  
Author(s):  
Esther Lapuente-Brun ◽  
Raquel Moreno-Loshuertos ◽  
Rebeca Acín-Pérez ◽  
Ana Latorre-Pellicer ◽  
Carmen Colás ◽  
...  

The textbook description of mitochondrial respiratory complexes (RCs) views them as free-moving entities linked by the mobile carriers coenzyme Q (CoQ) and cytochrome c (cyt c). This model (known as the fluid model) is challenged by the proposal that all RCs except complex II can associate in supercomplexes (SCs). The proposed SCs are the respirasome (complexes I, III, and IV), complexes I and III, and complexes III and IV. The role of SCs is unclear, and their existence is debated. By genetic modulation of interactions between complexes I and III and III and IV, we show that these associations define dedicated CoQ and cyt c pools and that SC assembly is dynamic and organizes electron flux to optimize the use of available substrates.


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1318.2-1318
Author(s):  
H. R. Lee ◽  
S. J. Yoo ◽  
J. Kim ◽  
I. S. Yoo ◽  
C. K. Park ◽  
...  

Background:Reactive oxygen species (ROS) and T helper 17 (TH17) cells have been known to play an important role in the pathogenesis of rheumatoid arthritis (RA). However, the interrelationship between ROS and TH17 remains unclear in RAObjectives:To explore whether ROS affect TH17 cells in peripheral blood mononuclear cells (PBMC) of RA patients, we analyzed ROS expressions among T cell subsets following treatment with mitochondrial electron transport chain complex inhibitors.Methods:Blood samples were collected from 40 RA patients and 10 healthy adult volunteers. RA activity was divided according to clinical parameter DAS28. PBMC cells were obtained from the whole blood using lymphocyte separation medium density gradient centrifugation. Following PBMC was stained with Live/Dead stain dye, cells were incubated with antibodies for CD3, CD4, CD8, and CD25. After fixation and permeabilization, samples were stained with antibodies for FoxP3 and IL-17A. MitoSox were used for mitochondrial specific staining.Results:The frequency of TH17 cells was increased by 4.83 folds in moderate disease activity group (5.1>DAS28≥3.2) of RA patients compared to healthy control. Moderate RA activity patients also showed higher ratio of TH17/Treg than healthy control (3.57 folds). All RA patients had elevated expression of mitochondrial specific ROS than healthy control. When PBMC cells were treated with 2.5uM of antimycin A (mitochondrial electron transport chain complex III inhibitor) for 16 h, the frequency of TH17 cells was significantly decreased.Conclusion:The mitochondrial electron transport chain complex III inhibitor markedly downregulated the frequency of TH17 cells in moderate disease activity patients with RA. These findings provide a novel approach to regulate TH17 function in RA through mitochondrial metabolism related ROS production.References:[1]Szekanecz, Z., et al., New insights in synovial angiogenesis. Joint Bone Spine, 2010. 77(1): p. 13-9.[2]Prevoo, M.L., et al., Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum, 1995. 38(1): p. 44-8.Disclosure of Interests:None declared


Sign in / Sign up

Export Citation Format

Share Document